share_log

CRISPR Therapeutics Q1 EPS $(1.43) Misses $(1.42) Estimate, Sales $504.00K Miss $28.11M Estimate

Benzinga ·  May 8 17:01

CRISPR Therapeutics (NASDAQ:CRSP) reported quarterly losses of $(1.43) per share which missed the analyst consensus estimate of $(1.42) by 0.7 percent. This is a 113.43 percent decrease over losses of $(0.67) per share from the same period last year. The company reported quarterly sales of $504.00 thousand which missed the analyst consensus estimate of $28.11 million by 98.21 percent. This is a 99.50 percent decrease over sales of $100.00 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment